RxDoctor Payments Data

Farrukh Munir

Hospitalist · York, PANPI 1720430648

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,367 of the $2,636 with a category attached, or 89.8%. It is spread thinly across 31 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,761, 8.2 times the $214 reported in 2023. Among hospitalist clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,636in general payments, 2019–2025

Across 117 payments — averaging $22.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$362
  • Daiichi Sankyo Inc.$353
  • Novartis$310
  • E.r. Squibb & Sons, L.L.C.$200
  • Johnson & Johnson$185
  • AbbVie$152
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$2,36790%
  • Education$26910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,636 in reported general payments places this provider in the 95th percentile of 1,287 hospitalist providers in Pennsylvania.

See all hospitalist providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$9,232
ValacyclovirValacyclovir Hcl15$585
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$555
Oxycodone Hcl26$499
Dexamethasone19$230
Levetiracetam15$184
Gabapentin12$150
Anastrozole11$69

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$49$9,23211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,287 hospitalist providers in Pennsylvania.

Other hospitalist in York

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →